
Bfflist AMO
Finnrick has tested 26 samples from Bfflist AMO across 3 products.
Finnrick Vendor Profile
to
Bfflist AMO
Tracking 3 products
26 total samples tested
Last test 25 Nov 2025
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Tirzepatide | 6 | 11 Jun 2025 | 25 Nov 2025 | |||||
| Retatrutide | 17 | 30 Jun 2025 | 23 Nov 2025 | |||||
| Semaglutide | 3 | 29 Jun 2025 | 25 Nov 2025 | |||||
Most recent Bfflist AMO tests
Samples are tested in commercial labs
26
tests
3
products
Scores
AVGMINMAX
First
11 Jun 2025
Last
25 Nov 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 25 Nov 2025 | Semaglutide | View | 10mg | 9.520mg | -4.8% | 99.46% | 106021 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 25 Nov 2025 | Tirzepatide | View | 60mg | 62.500mg | +4.2% | 99.95% | 608040 10/23/2025 | (no data) | Lab E | Public | |
| 23 Nov 2025 | Retatrutide | View | 30mg | 26.500mg | -11.7% | 99.90% | 309016-10/22/2025 | No Label / Silver Crimp / Blue Cap | Lab G | Public | |
| 18 Nov 2025 | Retatrutide | View | 30mg | 28.600mg | -4.7% | 99.81% | 309015-10/9/2025 | White Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 6 Nov 2025 | Retatrutide | View | 15mg | 13.100mg | -12.7% | 99.74% | 159015-9/17/2025 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 3 Nov 2025 | Retatrutide | View | 10mg | 8.900mg | -11.0% | 99.90% | 109020-8/7/2025 | No Label / Silver Crimp / Blue Cap | Lab G | Public | |
| 29 Oct 2025 | Retatrutide | View | 30mg | 28.200mg | -6.0% | 99.95% | 309011-9/17/2025 | Yellow Label / Gold Crimp / Blue Cap | Lab E | Public | |
Corrections
- 5 Nov 2025: Retatrutide
- These were remade and reanalyzed by Lab G. They traced the discrepancy to a likely human error during preparation.